Ahead of print

Original article

Association of Aqueous Humor Tumor Necrosis Factor Alpha with Retinal Ganglion Cell Thickness in Juvenile versus Adult-Onset Primary Open-Angle Glaucoma

Fitratul Ilahi ORCID
Fitrah Fitrah ORCID – Kalaj N. Haq ORCID – Muhammad Alfatih ORCID – Rivaldo S. Heriyanto ORCID

Full Text links

Keywords: primary open-angle glaucoma, juvenile open-angle glaucoma; TNF-α, retinal ganglion cell, RGC thickness

Summary

Aims: To evaluate the association between aqueous humor tumor necrosis factor alpha (TNF-α) and retinal ganglion cell (RGC) layer in patients with juvenile open-angle glaucoma (JOAG) and their comparison with adult-onset primary open-angle glaucoma patients (POAG).

Material and Methods: This analytical cross-sectional study included 15 JOAG patients (aged 7–40 years) and 15 POAG patients (> 40 years). Aqueous Humor (AH) samples were collected during trabeculectomy, TNF-α concentrations were measured using ELISA, and RGC thickness was assessed by Optical Coherence Tomography (Cirrus HD-OCT, Carl Zeiss). Group differences were analyzed using the independent t-test, and correlations were evaluated with Pearson’s test.

Results: The mean AH TNF-α level in the JOAG group (179.02 ±27.04 pg/mL) was significantly higher than in the POAG group (130.17 ±18.62 pg/mL; p < 0.001). Mean RGC thickness in JOAG (42.87 ±8.29 µm) was significantly lower than in POAG (58.13 ±14.86 µm; p = 0.004). There was a strong negative correlation between TNF-α levels and RGC thickness in both JOAG (r = -0.726; p = 0.02) and POAG (r = -0.807; p < 0.001).

Conclusion: Higher intraocular TNF-α levels and reduced RGC thickness in JOAG suggest a prominent neuroinflammatory contribution to early-onset glaucoma. Targeting TNF-α-mediated pathways may offer potential neuroprotective benefits in younger glaucoma patients.

References

  1. Quigley HA. Glaucoma. The Lancet. 2011;377:1367-1377.
  2. Tanna A, Boland M, Giaconi A. Primary Open-Angle Glaucoma. Basic Clin Sci Course, San Fransisco: American Academy of Ophthalmology; 2023, p. 113-124.
  3. WHO. Blindness and vision impairment [Internet]. WHO; 2023. Available from: https://www.who.int/news-room/fact-sheets/detail/blindness-and-visual-impairment
  4. Zhang N, Wang J, Li Y, Jiang B. Prevalence of primary open angle glaucoma in the last 20 years: a meta-analysis and systematic review. Sci Rep. 2021;11(1):1-12.
  5. Kementrian Kesehatan Republik Indonesia. Laporan Hasil Riset Kesehatan Dasar (RISKESDAS) Provinsi Sumatera Barat Tahun 2007 Jakarta: Balitbangkes; 2007.
  6. Seth PK, Senthil S, Das AV, et al. Prevalence of glaucoma types, clinical profile and disease severity at presentation: Tertiary Institute based cross-sectional study from South India. Indian J Ophthalmol. 2023;71(10):3305-3312.
  7. Jafer Chardoub AA, Zeppieri M, Blair K. Juvenile Glaucoma. Stat- Pearls, Treasure Island (FL): StatPearls Publishing; 2025.
  8. Muma K, Mboni C, Mwale C, et al. Juvenile-onset Open-Angle Glaucoma at the University Teaching Hospitals - Eye Hospital, Lusaka Zambia. Med J Zambia. 2020;47:112-124.
  9. Lai W, Wu X, Wang D, et al. Developmental characteristics of the cytokine profile in aqueous humor and its relationship with the inflammatory response in children. Ann Transl Med. 2020;8:1542.
  10. Maidenko KM. Primary Open Angle Glaucoma: Mechanisms of Pathogenesis And Genetic Predisposition. Med Sci Ukr. 2022;18:89-102.
  11. Mélik Parsadaniantz S, Réaux-le Goazigo A, Sapienza A, et al. Glaucoma: A Degenerative Optic Neuropathy Related to Neuroinflammation? Cells. 2020;9(3):1-14
  12. Munemasa Y, Kitaoka Y. Molecular mechanisms of retinal ganglion cell degeneration in glaucoma and future prospects for cell body and axonal protection. Front Cell Neurosci. 2012;6:1-13.
  13. Evangelho K, Mogilevskaya M, Losada-Barragán M, et al. Pathophysiology of primary open-angle glaucoma from a neuroinflammatory and neurotoxicity perspective: a review. Int Ophthalmol. 2019;39(1):259-271.
  14. Fernández-Albarral JA, Ramírez AI, de Hoz R, et al. Glaucoma: from pathogenic mechanisms to retinal glial cell response to damage. Front Cell Neurosci. 2024;18:1.
  15. Kondkar AA, Sultan T, Almobarak FA, et al. Association of increased levels of plasma tumor necrosis factor alpha with primary open-angle glaucoma. Clin Ophthalmol. 2018;12:701-706.
  16. Dammak A, Naves JS, Huete-Toral F, et al. New Biomarker Combination Related to Oxidative Stress and Inflammation in Primary Open-Angle Glaucoma. Life. 2023;13(7):1-16
  17. Agarwal R, Agarwal P. Glaucomatous neurodegeneration: An eye on tumor necrosis factor-alpha. Indian J Ophthalmol. 2012;60:255- 261.
  18. Cueva Vargas JL, Osswald IK, Unsain N, et al. Soluble Tumor Necrosis Factor Alpha Promotes Retinal Ganglion Cell Death in Glaucoma via Calcium-Permeable AMPA Receptor Activation. J Neurosci. 2015;35:12088-12102.
  19. Balaiya S, Edwards J, Tillis T, et al. Tumor necrosis factor-alpha (TNF-α) levels in aqueous humor of primary open angle glaucoma. Clin Ophthalmol Auckl NZ. 2011;5:553-556.
  20. Tong Y, Zhou Y-L, Zheng Y, et al. Analyzing cytokines as biomarkers to evaluate severity of glaucoma. Int J Ophthalmol. 2017;10:925-
  21. Jung Y, Ohn K, Shin H, et al. Factors Associated with Elevated Tumor Necrosis Factor-α in Aqueous Humor of Patients with Open-Angle Glaucoma. J Clin Med. 2022;11(17):1-10.
  22. Gupta V, Ganesan VL, Kumar S, et al. Visual Disability Among Juvenile Open-angle Glaucoma Patients. J Glaucoma. 2018;27:e87-89.
  23. Vidal-Villegas B, Burgos-Blasco B, Santiago Alvarez JL, et al. Proinflammatory Cytokine Profile Differences between Primary Open-Angle and Pseudoexfoliative Glaucoma. Ophthalmic Res. 2021;65:111-120.
  24. Ebneter A, Casson RJ, Wood JPM, et al. Microglial Activation in the Visual Pathway in Experimental Glaucoma: Spatiotemporal Characterization and Correlation with Axonal Injury. Invest Ophthalmol Vis Sci. 2010;51:6448-6460.
  25. Ramirez AI, de Hoz R, Salobrar-Garcia E, et al. The Role of Microglia in Retinal Neurodegeneration: Alzheimer’s Disease, Parkinson, and Glaucoma. Front Aging Neurosci. 2017;9:146
  26. Hu X, Xu MX, Zhou H, et al. Tumor necrosis factor-alpha aggravates gliosis and inflammation of activated retinal Müller cells. Biochem Biophys Res Commun 2020;531:383-389.
  27. Lambuk L, Ahmad S, Sadikan MZ, et al. Targeting Differential Roles of Tumor Necrosis Factor Receptors as a Therapeutic Strategy for Glaucoma. Front Immunol 2022;13.
  28. Burgos-Blasco B, Vidal-Villegas B, Saenz-Frances F, et al. Tear and aqueous humour cytokine profile in primary open-angle glaucoma. Acta Ophthalmol (Copenh) 2020;98:e768-772.